Client login From 24 June 2024, the new name for Across Health is Precision AQ!…. Read more

Discover the impact of COVID-19 in our industry and what do doctors want from pharma

Industry insights

Across Health just released the results of the Snapshot survey, looking at the impact of COVID-19 within the industry, and our hot-of-the-press Navigator365™ Spotcheck report on HCPs' preferences during the coronavirus outbreak, with 300 EU5 GPs and specialists.

Discover what pharma companies are up to
during COVID-19 times in our
3rd Maturometer Snapshot

ACCESS the results

 

 

Find the results of the Navigator365™ Spotcheck
report on ‘What HCPs want from Pharma"
in this new, remote reality

DOWNLOAD the report

Is there any question left unanswered or do you want to have a chat about the challenges you're facing? Please do reach out to us


Want to receive the Across Health newsletter?


Or follow us on  LinkedIn

+

Share this article

Use your preferred feature.


Or share this page with a colleague.

+

Healthcare Innovation Tour 2020

To register your interest in joining the tour, and to comply with GDPR so we may send you future emails, please fill out the following information and complete the consent section at the bottom.

+

+

Book an exploratory call

Submit your details via this short form and you will be invited by one of our experts for a free 30-minute call to explore how Navigator365TM can provide an answer to your ambitions, needs and challenges.

+
+

Submit your details

+

Webinar FAQ

Fill out this short form to get access to evidence-led insights and answers to the most frequently asked questions on the topic of this webinar!

+

Across Health is evolving...

From 24 June 2024, the new name for Across Health is Precision AQ! This change is happening in-line with the rebranding being undertaken by the entire Precision Value & Health team (of which we have been a part since February 2021).

Having joined forces with over 1,200 life-science experts, advisors and creatives across 100+ diverse fields, we will continue to partner with our clients to deliver evidence-based omnichannel engagement strategies while empowering access to life-changing medicines for all.

While we transition across to our new website, click here to see how we are already focusing on HCP engagement in the digital age, fuelled by powerful insights from our Navigator365TM research.

To find out more about our wider global services and unified mission, read our publication here.

+